Strategies for Pharmacists to Overcome Current Challenges and Integrate Novel Maintenance Therapies for the Management of COPD

Gain invaluable insights into updates in chronic obstructive pulmonary disease with this interactive text module, expert ClinicalThought commentary, and downloadable slideset. Faculty will highlight important updates in the 2024 GOLD Report, including new strategies for maintenance therapy, considerations on device selection, and emerging biologic therapies.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by ProCE, LLC

Supporters

This program is supported in part by an independent medical educational grant from Mylan Specialty L.P., a Viatris Company and Theravance Biopharma Inc.

Mylan Specialty L.P., a Viatris Company

Theravance Biopharma Inc.